ID

17148

Description

MDS Score CMML-Specific Prognostic Scoring System Such E, Germing U, Malcovati L, Cervera J, Kuendgen A, Della Porta MG, Nomdedeu B, Arenillas L, Luno E, Xicoy B, Amigo ML, Valcarcel D, Nachtkamp K, Ambaglio I, Hildebrandt B, Lorenzo I, Cazzola M, Sanz G. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013;121(15):3005-15. PMID: 23372164. doi: 10.1182/blood-2012-08-452938.

Mots-clés

  1. 28/08/2016 28/08/2016 -
Téléchargé le

28 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC-ND 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

MDS Score CMML-Specific Prognostic Scoring System

MDS Score CMML-Specific Prognostic Scoring System

Score: Items
Description

Score: Items

Alias
UMLS CUI-1
C0559741
WHO Types:
Description

CMML

Type de données

text

Alias
UMLS CUI [1]
C0023480
Leukocytes
Description

Leukocytes

Type de données

float

Unités de mesure
  • /μl
Alias
UMLS CUI [1]
C0023508
/μl
Risk Group: Karyotype
Description

Low = normal and isolated -Y Intermediate = other aberration High = Trisomy 8, Chromosome 7 Aberrations, complex karyotype

Type de données

text

Alias
UMLS CUI [1]
C1261273
Patient is dependent on blood transfusion? (at least one red blood transfusion in 8 weeks over a time period of 4 months)
Description

Dependency on blood transufsion

Type de données

boolean

Alias
UMLS CUI [1,1]
C1546937
UMLS CUI [1,2]
C0005841
Result of Score
Description

Result of Score

Alias
UMLS CUI-1
C0449820
UMLS CUI-2
C1274040
Prognostic Risk Group?
Description

Prognostic Risk Group: Low; Score: 0; Overall Survival (Median, in months): 72; AML 25 %(Median, in months): 95 Prognostic Risk Group: Intermediate I; Score: 1; Overall Survival (Median, in months): 31; AML 25 %(Median, in months): 40 Prognostic Risk Group: Intermediate II; Score: 2-3; Overall Survival (Median, in months): 13; AML 25 %(Median, in months): 11 Prognostic Risk Group: High; Score: 4-5; Overall Survival (Median, in months): 5; AML 25 %(Median, in months): 4

Type de données

text

Alias
UMLS CUI [1,1]
C0220901
UMLS CUI [1,2]
C0684030
CPSS Score
Description

CPSS Score

Type de données

text

Alias
UMLS CUI [1,1]
C0023480
UMLS CUI [1,2]
C0449820

Similar models

MDS Score CMML-Specific Prognostic Scoring System

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Score: Items
C0559741 (UMLS CUI-1)
Item
WHO Types:
text
C0023480 (UMLS CUI [1])
Code List
WHO Types:
CL Item
CMML I (CMML I)
CL Item
CMML II (CMML II)
Leukocytes
Item
Leukocytes
float
C0023508 (UMLS CUI [1])
Item
Risk Group: Karyotype
text
C1261273 (UMLS CUI [1])
Code List
Risk Group: Karyotype
CL Item
Low  (Low )
CL Item
Intermediate (Intermediate)
CL Item
High (High)
Dependency on blood transufsion
Item
Patient is dependent on blood transfusion? (at least one red blood transfusion in 8 weeks over a time period of 4 months)
boolean
C1546937 (UMLS CUI [1,1])
C0005841 (UMLS CUI [1,2])
Item Group
Result of Score
C0449820 (UMLS CUI-1)
C1274040 (UMLS CUI-2)
Item
Prognostic Risk Group?
text
C0220901 (UMLS CUI [1,1])
C0684030 (UMLS CUI [1,2])
Code List
Prognostic Risk Group?
CL Item
High Risk (High Risk)
CL Item
Intermediate Risk (Intermediate Risk)
CL Item
Low Risk (Low Risk)
CL Item
Very High Risk (Very High Risk)
CL Item
Very Low Risk (Very Low Risk)
CPSS Score
Item
CPSS Score
text
C0023480 (UMLS CUI [1,1])
C0449820 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial